Search Results

240 results for CEL

Watch S&P 1,173

A break below this level would establish a new downtrend.

Celsius Crypto Rocked by Lawsuit and Fund Mismanagement Allegations

The Celsius crypto is suffering hefty losses today as the company finds itself involved in a full-fledged lawsuit.

The Top 5 Stocks Cathie Wood Bought and Sold This Week

Cathie Wood’s flagship ETF, the ARK Innovation ETF, hit a five-year and 52-week low this week, casting doubts on the investment manager.

Hottest Services Stocks Now – FDO DG RBA ODP

Services stocks advanced broadly on Wall Street so far on Monday, with the sector seeing an overall increase of 0.2%.

Hottest Services Stocks Now – IRM MPEL MDCA CHU

Services stocks fell 0.5% on Wall Street on Thursday morning.

Can the Bulls Break S&P 1,200?

A breakout above this level will change the sentiment of the market.

8 Biotechnology Stocks to Sell Now

This week, the overall grades of eight biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…

7 Top Global Dividend Stocks to Buy

Income investors willing to look beyond our borders can find generous yields with greater growth potential.

Micron’s Run Looks Unstoppable. Here’s the One Number We’re Watching.

Luke Lango breaks down the AI memory boom with Matt Weinschenk, including why this cycle differs from past ones, and the single signal that will…

9 Biotechnology Stocks to Sell Now

For the current week, the overall ratings of nine biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a “D” (“sell”)…

9 Biotechnology Stocks to Sell Now

The ratings of nine biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F”…

9 Biotechnology Stocks to Sell Now

The ratings of nine biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F”…

9 Biotechnology Stocks to Sell Now

The ratings of nine biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F”…

9 Biotechnology Stocks to Sell Now

The overall ratings of nine biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…

Do Cryptos Really Need Regulation?

Regulation be the basis for cryptos moving even higher. And it’ll bring some clarity and certainty to these markets.

10 Biotechnology Stocks to Sell Now

This week, the overall grades of 10 biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…

10 Biotechnology Stocks to Sell Now

The overall ratings of 10 biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…

10 Biotechnology Stocks to Sell Now

This week, the ratings of 10 biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

10 Biotechnology Stocks to Sell Now

This week, the ratings of 10 biotechnology stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

10 Biotechnology Stocks to Sell Now

This week, the overall grades of 10 biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…

10 Biotechnology Stocks to Sell Now

The overall ratings of 10 biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…

10 Biotechnology Stocks to Sell Now

For the current week, the overall ratings of 10 biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a “D” (“sell”)…

3 Cathie Wood Stocks Set to Explode Higher

Delve into the exciting world of Cathie Wood Stocks where potential meets performance, offering investors hefty long-term upside.

10 Biotechnology Stocks to Sell Now

The overall ratings of 10 biotechnology stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…

6 – 10 of 240 results